Cybin (TSE:CYBN) has released an update.
Cybin Inc., a leader in developing psychedelic-based therapeutics for mental health, will be featured in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference with CEO Doug Drysdale presenting in a fireside chat. The chat will be available on-demand starting June 27, 2024, and accessible through the company’s website. Cybin is advancing its mission to transform mental healthcare with proprietary compounds like CYB003 and CYB004, currently under development for major depressive and anxiety disorders.
For further insights into TSE:CYBN stock, check out TipRanks’ Stock Analysis page.
